The N06B class of drugs a therapeutic subgroup of the Anatomical Therapeutic
Chemical Classification System, a system of alphanumeric codes developed by the
World Health Organisation (WHO) for the classification of drugs and other
medical products. It covers drugs designed to attention-deficit hyperactivity
disorder (ADHD) and to improve impaired cognitive abilities.

Details of drugs included in the category can be found here:
http://www.whocc.no/atc_ddd_index/?code=N06B
